Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0ZY2T
|
||||
| Former ID |
DNC011811
|
||||
| Drug Name |
PO3 2-Leu-Nal-O-3K
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H22K3N2O6P
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NC(CC1=CC=CC2=CC=CC=C21)C(=O)[O-])NP(=O)([<br />O-])[O-].[K+].[K+].[K+]
|
||||
| InChI |
1S/C19H25N2O6P.3K/c1-12(2)10-16(21-28(25,26)27)18(22)20-17(19(23)24)11-14-8-5-7-13-6-3-4-9-15(13)14;;;/h3-9,12,16-17H,10-11H2,1-2H3,(H,20,22)(H,23,24)(H3,21,25,26,27);;;/q;3*+1/p-3/t16-,17-;;;/m0.../s1
|
||||
| InChIKey |
IKWJKNJQTURPIW-YKRIILNKSA-K
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Endothelin-converting enzyme 1 | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Endothelin signaling pathway | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Corticotropin-releasing hormone | |||||
| Endothelin Pathways | |||||
| References | |||||
| REF 1 | Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.